CLINICAL TRIALS PROFILE FOR ETHINYL ESTRADIOL; ETONOGESTREL

All Clinical Trials for ETHINYL ESTRADIOL; ETONOGESTREL

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00369967 ↗	Quick Start Initiation of the Contraceptive Vaginal Ring in Adolescents	Terminated	American College of Obstetricians and Gynecologists	N/A	2007-02-01	We hypothesize that using "quick start" initiation of the contraceptive vaginal ring in adolescents seeking birth control will improve compliance compared to traditional start. We will conduct a randomized controlled trial comparing "quick start" to traditional start initiation of the contraceptive vaginal ring in adolescents seeking birth control. The primary study outcome is method continuation at 3, 6, and 12 months. Secondary outcomes include abnormal bleeding, product satisfaction, and adverse events.
NCT00369967 ↗	Quick Start Initiation of the Contraceptive Vaginal Ring in Adolescents	Terminated	Bayer	N/A	2007-02-01	We hypothesize that using "quick start" initiation of the contraceptive vaginal ring in adolescents seeking birth control will improve compliance compared to traditional start. We will conduct a randomized controlled trial comparing "quick start" to traditional start initiation of the contraceptive vaginal ring in adolescents seeking birth control. The primary study outcome is method continuation at 3, 6, and 12 months. Secondary outcomes include abnormal bleeding, product satisfaction, and adverse events.
NCT00369967 ↗	Quick Start Initiation of the Contraceptive Vaginal Ring in Adolescents	Terminated	Virginia Commonwealth University	N/A	2007-02-01	We hypothesize that using "quick start" initiation of the contraceptive vaginal ring in adolescents seeking birth control will improve compliance compared to traditional start. We will conduct a randomized controlled trial comparing "quick start" to traditional start initiation of the contraceptive vaginal ring in adolescents seeking birth control. The primary study outcome is method continuation at 3, 6, and 12 months. Secondary outcomes include abnormal bleeding, product satisfaction, and adverse events.
NCT00612508 ↗	Hormonal Contraception and Vaginal Health	Completed	Oregon Clinical and Translational Research Institute	N/A	2007-05-01	The purpose of this study is to help determine if the route by which women receive hormonal contraception causes different changes to occur in the lining of the vagina. The investigators plan to compare an oral route (taking birth control pills) with a vaginal route (using a vaginal ring).

Clinical Trial Conditions for ETHINYL ESTRADIOL; ETONOGESTREL

Condition Name

Condition Name for ETHINYL ESTRADIOL; ETONOGESTREL
Intervention	Trials
Contraception	3
Pregnancy Prevention	1
Tuberculosis	1
Bioequivalence	1

Condition MeSH

Condition MeSH for ETHINYL ESTRADIOL; ETONOGESTREL
Intervention	Trials
Vaginal Diseases	1
HIV Infections	1
Thinness	1
Tuberculosis	1

Clinical Trial Locations for ETHINYL ESTRADIOL; ETONOGESTREL

Trials by Country

Trials by Country for ETHINYL ESTRADIOL; ETONOGESTREL
Location	Trials
United States	16
Peru	3
South Africa	3
Brazil	2
Thailand	2

Trials by US State

Trials by US State for ETHINYL ESTRADIOL; ETONOGESTREL
Location	Trials
Colorado	2
New York	2
Virginia	2
Rhode Island	1
Ohio	1

Clinical Trial Progress for ETHINYL ESTRADIOL; ETONOGESTREL

Clinical Trial Phase

Clinical Trial Phase for ETHINYL ESTRADIOL; ETONOGESTREL
Clinical Trial Phase	Trials
Phase 4	4
Phase 3	1
Phase 2	2

Clinical Trial Status

Clinical Trial Status for ETHINYL ESTRADIOL; ETONOGESTREL
Clinical Trial Phase	Trials
Completed	5
Not yet recruiting	2
Recruiting	2

Clinical Trial Sponsors for ETHINYL ESTRADIOL; ETONOGESTREL

Sponsor Name

Sponsor Name for ETHINYL ESTRADIOL; ETONOGESTREL
Sponsor	Trials
Merck Sharp & Dohme Corp.	4
Eastern Virginia Medical School	1
American College of Obstetricians and Gynecologists	1

Sponsor Type

Sponsor Type for ETHINYL ESTRADIOL; ETONOGESTREL
Sponsor	Trials
Other	13
Industry	9
NIH	1